
Sponsored
Advertisement


Advertisement




Advertisement

The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.

As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections
2
In A Matter of Months, MMR Vaccine Confidence Drops Significantly
3
Listeria Outbreak Update: 27 Illnesses and 6 Deaths Linked to Packaged Meals
4
Clesrovimab Lowers RSV Hospitalizations and Illness in Healthy Infants
5
